Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × camrelizumab × 90 days × Clear all

NCT05213884 2026-04-24

The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck